{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/187125142"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Now, with the Forest deal, Actavis is expected to have combined annual sales of more than $15 billion in 2015.The Dublin, Ireland-based drugmaker's portfolio includes some 1,000 generic, branded generic, branded proprietary and over-the-counter pharmaceuticals for hypertension, pain, sleep disorders and other ailments." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "investors.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/344632621"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/187125142" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/7198136"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/187125142"] } } }
